* Accuray Inc ARAY.OQ reported quarterly adjusted earnings
of 2
cents per share for the quarter ended December 31, higher than
the same quarter last year, when the company reported EPS of -10
cents. The mean expectation of four analysts for the quarter
was for a loss of 2 cents per share. Wall Street expected
results to range from -5 cents tozero cents per share.
* Revenue rose 8.3% to $116.17 million from a year ago;
analysts
expected $110.36 million.
* Accuray Inc's reported EPS for the quarter was 2 cents.
* The company reported quarterly net income of $2.54
million.
* Accuray Inc shares had risen by 17.7% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is "buy."
Wall Street's median 12-month price target for Accuray Inc is
$6.00
This summary was machine generated from LSEG data February 5 at
10:02 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 -0.02 0.02 Beat
Sep. 30 2024 -0.05 -0.04 Beat
Jun. 30 2024 0.03 0.03 Met
Mar. 31 2024 -0.01 -0.06 Missed